Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives
Ema Ozaki,1 Matthew Campbell,1 Sarah L Doyle2,3 1Department of Genetics, 2Department of Clinical Medicine, School of Medicine, Trinity College Dublin, 3National Children's Research Centre, Our Lady's Children's Hospital Crumlin, Dublin, Ireland Abstract: The inflammasome is...
Enregistré dans:
Auteurs principaux: | Ozaki E, Campbell M, Doyle SL |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2015
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/db090e7b71ab4be5a2c720688d371a9f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The role of the NLRP3 inflammasome in gout
par: Sarah R Kingsbury, et autres
Publié: (2011) -
Inflammatory cytokines and atrial fibrillation: current and prospective views
par: Hadi AR Hadi, et autres
Publié: (2010) -
Current perspectives on the role of IL-17 in autoimmune disease
par: Hisakata Yamada
Publié: (2010) -
Spotlight on the NLRP3 inflammasome pathway
par: Groslambert M, et autres
Publié: (2018) -
Progress and perspectives on the role of RPE cell inflammatory responses in the development of age-related macular degeneration
par: Suofu Qin, et autres
Publié: (2008)